JS

Jamal Shahid

Active Director Director DIN 08179601
DIN 08179601 First appointment Aug 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Jamal Shahid

Data last updated:

Jamal Shahid is a Director at Cure Line Aj Pharmaceuticals Private Limited (since 2018). The company operates in Healthcare.

DIN 08179601
Primary Designation Director
Industry Healthcare
First Appointment 28 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Aug 20182018Active

Board colleagues of Jamal Shahid

NameDINCompanyDesignation
Mohd Ajij08179628Cure Line Aj Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cure Line Aj Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jamal Shahid

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jamal Shahid

Jamal Shahid currently holds 1 directorship: Cure Line Aj Pharmaceuticals Private Limited (Director, since 28 Aug 2018).

Jamal Shahid was first appointed on 28 Aug 2018 as Director at Cure Line Aj Pharmaceuticals Private Limited.

The current boards of Jamal Shahid's companies include Mohd Ajij (Cure Line Aj Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available